Cargando…
Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462530/ https://www.ncbi.nlm.nih.gov/pubmed/37561357 http://dx.doi.org/10.1007/s11060-023-04408-1 |
| _version_ | 1785098052809261056 |
|---|---|
| author | Lawson McLean, Aaron |
| author_facet | Lawson McLean, Aaron |
| author_sort | Lawson McLean, Aaron |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10462530 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104625302023-08-30 Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib Lawson McLean, Aaron J Neurooncol Correspondence Springer US 2023-08-10 2023 /pmc/articles/PMC10462530/ /pubmed/37561357 http://dx.doi.org/10.1007/s11060-023-04408-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Lawson McLean, Aaron Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib |
| title | Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib |
| title_full | Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib |
| title_fullStr | Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib |
| title_full_unstemmed | Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib |
| title_short | Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib |
| title_sort | prognostic significance of baseline thyroid variables in idh-wildtype glioblastoma patients treated with regorafenib |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462530/ https://www.ncbi.nlm.nih.gov/pubmed/37561357 http://dx.doi.org/10.1007/s11060-023-04408-1 |
| work_keys_str_mv | AT lawsonmcleanaaron prognosticsignificanceofbaselinethyroidvariablesinidhwildtypeglioblastomapatientstreatedwithregorafenib |